Long-term survival with pemetrexed-based chemotherapy in a patient with metastatic lung adenocarcinoma of unclear primary origin harboring MTHFR C677T(T/T) mutation: a case report
This case report presents a patient with metastatic adenocarcinoma of unclear primary focus at initial presentation and revealed lung adenocarcinoma in subsequent follow-up. The patient has been surviving for more than 10 years after pemetrexed-based treatment and local radiotherapy. Sequential gene...
Saved in:
Main Authors: | Yuan Yu, Nan-Jing Li, Jin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2024.1435357/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta Analysis of Methylenetetrahydrofolate Reductase (MTHFR) C677T polymorphism and its association with folate and colorectal cancer
by: Meng Ye, et al.
Published: (2025-01-01) -
FV Leiden, Prothrombin II, and MTHFR C677T Mutations in Children and Young Adults with Thromboembolic Diseases
by: Sura O. AL-Dewachi, et al.
Published: (2024-12-01) -
The Relationship between Homocysteine Levels, MTHFR C677T and A1298C Polymorphism, and Pregnancy Outcomes in Georgian Women with Polycystic Ovary Syndrome: A Case-Control Study
by: Elene Asanidze, et al.
Published: (2025-01-01) -
Methods for preliminary determination of pemetrexed in macromolecular drug-carrier systems
by: Ciekot Jarosław, et al.
Published: (2016-03-01) -
CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway
by: Hao Qu, et al.
Published: (2025-01-01)